Are you Dr. Driscoll?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 66 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2355 Poplar Level Rd
Suite 405
Louisville, KY 40217Phone+1 502-636-7845Fax+1 502-636-8045
Summary
- Dr. Michael Driscoll, MD is an oncologist in Louisville, Kentucky. He is currently licensed to practice medicine in Kentucky and Indiana. He is affiliated with Norton Audubon Hospital, Norton Children's Hospital, and Norton Hospital.
Education & Training
University of Louisville School of MedicineFellowship, Hematology and Medical Oncology, 2008 - 2011- University of Louisville School of MedicineResidency, Internal Medicine, 2006 - 2008
Tulane UniversityResidency, Internal Medicine, 2005 - 2005
LSU School of Medicine in ShreveportClass of 2005
Certifications & Licensure
IN State Medical License 2011 - 2025
KY State Medical License 2009 - 2025- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced Pancreatic Cancer Start of enrollment: 2019 May 10
- A Study of Nivolumab in Combination With Ipilimumab in Participants With Advanced Hepatocellular Carcinoma Start of enrollment: 2019 Sep 30
Publications & Presentations
PubMed
- 20 citationsDrug-Eluting Bead, Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin.Robert C G Martin 2nd, Kerri A Simo, Paul Hansen, Flavio Rocha, Prejesh Philips
Annals of Surgical Oncology. 2022-09-01 - ASO Visual Abstract: Drug-Eluting Beads with Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisp...Robert C G Martin 2nd, Kerri A Simo, Paul Hansen, Flavio Rocha, Prejesh Philips
Annals of Surgical Oncology. 2022-09-01 - 52 citationsTherapeutic potential of various β-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapyMichael F Driscoll, Richard Hansen, Chuanlin Ding, Daniel E. Cramer, Jun Yan
Cancer Biology & Therapy. 2009-02-01
